The global Molecular Diagnostics Systems market size was valued at USD 11200 million in 2023 and is forecast to a readjusted size of USD 15050 million by 2030 with a CAGR of 4.3% during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The publisher report includes an overview of the development of the Molecular Diagnostics Systems industry chain, the market status of Hospitals (PCR, Hybridization), Laboratories (PCR, Hybridization), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Molecular Diagnostics Systems.
Regionally, the report analyzes the Molecular Diagnostics Systems markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Molecular Diagnostics Systems market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Molecular Diagnostics Systems market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Molecular Diagnostics Systems industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., PCR, Hybridization).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Molecular Diagnostics Systems market.
Regional Analysis: The report involves examining the Molecular Diagnostics Systems market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Molecular Diagnostics Systems market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Molecular Diagnostics Systems:
Company Analysis: Report covers individual Molecular Diagnostics Systems manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Molecular Diagnostics Systems This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Laboratories).
Technology Analysis: Report covers specific technologies relevant to Molecular Diagnostics Systems. It assesses the current state, advancements, and potential future developments in Molecular Diagnostics Systems areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Molecular Diagnostics Systems market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Molecular Diagnostics Systems market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
PCR
Hybridization
DNA Sequencing
Market segment by Application
Hospitals
Laboratories
Major players covered
Abbott Laboratories
Qiagen N.V.
Roche Diagnostics
Hologic, Inc.
Grifols
Siemens Healthcare
Becton, Dickinson and Company
Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
Biom茅rieux Sa
Cepheid Inc
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Molecular Diagnostics Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Molecular Diagnostics Systems, with price, sales, revenue and global market share of Molecular Diagnostics Systems from 2019 to 2024.
Chapter 3, the Molecular Diagnostics Systems competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Molecular Diagnostics Systems breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Molecular Diagnostics Systems market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Molecular Diagnostics Systems.
Chapter 14 and 15, to describe Molecular Diagnostics Systems sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Molecular Diagnostics Systems
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Molecular Diagnostics Systems Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 PCR
1.3.3 Hybridization
1.3.4 DNA Sequencing
1.4 Market Analysis by Application
1.4.1 Overview: Global Molecular Diagnostics Systems Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Laboratories
1.5 Global Molecular Diagnostics Systems Market Size & Forecast
1.5.1 Global Molecular Diagnostics Systems Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Molecular Diagnostics Systems Sales Quantity (2019-2030)
1.5.3 Global Molecular Diagnostics Systems Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Molecular Diagnostics Systems Product and Services
2.1.4 Abbott Laboratories Molecular Diagnostics Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbott Laboratories Recent Developments/Updates
2.2 Qiagen N.V.
2.2.1 Qiagen N.V. Details
2.2.2 Qiagen N.V. Major Business
2.2.3 Qiagen N.V. Molecular Diagnostics Systems Product and Services
2.2.4 Qiagen N.V. Molecular Diagnostics Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Qiagen N.V. Recent Developments/Updates
2.3 Roche Diagnostics
2.3.1 Roche Diagnostics Details
2.3.2 Roche Diagnostics Major Business
2.3.3 Roche Diagnostics Molecular Diagnostics Systems Product and Services
2.3.4 Roche Diagnostics Molecular Diagnostics Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Roche Diagnostics Recent Developments/Updates
2.4 Hologic, Inc.
2.4.1 Hologic, Inc. Details
2.4.2 Hologic, Inc. Major Business
2.4.3 Hologic, Inc. Molecular Diagnostics Systems Product and Services
2.4.4 Hologic, Inc. Molecular Diagnostics Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Hologic, Inc. Recent Developments/Updates
2.5 Grifols
2.5.1 Grifols Details
2.5.2 Grifols Major Business
2.5.3 Grifols Molecular Diagnostics Systems Product and Services
2.5.4 Grifols Molecular Diagnostics Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Grifols Recent Developments/Updates
2.6 Siemens Healthcare
2.6.1 Siemens Healthcare Details
2.6.2 Siemens Healthcare Major Business
2.6.3 Siemens Healthcare Molecular Diagnostics Systems Product and Services
2.6.4 Siemens Healthcare Molecular Diagnostics Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Siemens Healthcare Recent Developments/Updates
2.7 Becton, Dickinson and Company
2.7.1 Becton, Dickinson and Company Details
2.7.2 Becton, Dickinson and Company Major Business
2.7.3 Becton, Dickinson and Company Molecular Diagnostics Systems Product and Services
2.7.4 Becton, Dickinson and Company Molecular Diagnostics Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Becton, Dickinson and Company Recent Developments/Updates
2.8 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
2.8.1 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Details
2.8.2 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Major Business
2.8.3 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Product and Services
2.8.4 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Recent Developments/Updates
2.9 Biom茅rieux Sa
2.9.1 Biom茅rieux Sa Details
2.9.2 Biom茅rieux Sa Major Business
2.9.3 Biom茅rieux Sa Molecular Diagnostics Systems Product and Services
2.9.4 Biom茅rieux Sa Molecular Diagnostics Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Biom茅rieux Sa Recent Developments/Updates
2.10 Cepheid Inc
2.10.1 Cepheid Inc Details
2.10.2 Cepheid Inc Major Business
2.10.3 Cepheid Inc Molecular Diagnostics Systems Product and Services
2.10.4 Cepheid Inc Molecular Diagnostics Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Cepheid Inc Recent Developments/Updates
3 Competitive Environment: Molecular Diagnostics Systems by Manufacturer
3.1 Global Molecular Diagnostics Systems Sales Quantity by Manufacturer (2019-2024)
3.2 Global Molecular Diagnostics Systems Revenue by Manufacturer (2019-2024)
3.3 Global Molecular Diagnostics Systems Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Molecular Diagnostics Systems by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Molecular Diagnostics Systems Manufacturer Market Share in 2023
3.4.2 Top 6 Molecular Diagnostics Systems Manufacturer Market Share in 2023
3.5 Molecular Diagnostics Systems Market: Overall Company Footprint Analysis
3.5.1 Molecular Diagnostics Systems Market: Region Footprint
3.5.2 Molecular Diagnostics Systems Market: Company Product Type Footprint
3.5.3 Molecular Diagnostics Systems Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Molecular Diagnostics Systems Market Size by Region
4.1.1 Global Molecular Diagnostics Systems Sales Quantity by Region (2019-2030)
4.1.2 Global Molecular Diagnostics Systems Consumption Value by Region (2019-2030)
4.1.3 Global Molecular Diagnostics Systems Average Price by Region (2019-2030)
4.2 North America Molecular Diagnostics Systems Consumption Value (2019-2030)
4.3 Europe Molecular Diagnostics Systems Consumption Value (2019-2030)
4.4 Asia-Pacific Molecular Diagnostics Systems Consumption Value (2019-2030)
4.5 South America Molecular Diagnostics Systems Consumption Value (2019-2030)
4.6 Middle East and Africa Molecular Diagnostics Systems Consumption Value (2019-2030)
5 Market Segment by Type
5.1 Global Molecular Diagnostics Systems Sales Quantity by Type (2019-2030)
5.2 Global Molecular Diagnostics Systems Consumption Value by Type (2019-2030)
5.3 Global Molecular Diagnostics Systems Average Price by Type (2019-2030)
6 Market Segment by Application
6.1 Global Molecular Diagnostics Systems Sales Quantity by Application (2019-2030)
6.2 Global Molecular Diagnostics Systems Consumption Value by Application (2019-2030)
6.3 Global Molecular Diagnostics Systems Average Price by Application (2019-2030)
7 North America
7.1 North America Molecular Diagnostics Systems Sales Quantity by Type (2019-2030)
7.2 North America Molecular Diagnostics Systems Sales Quantity by Application (2019-2030)
7.3 North America Molecular Diagnostics Systems Market Size by Country
7.3.1 North America Molecular Diagnostics Systems Sales Quantity by Country (2019-2030)
7.3.2 North America Molecular Diagnostics Systems Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
8.1 Europe Molecular Diagnostics Systems Sales Quantity by Type (2019-2030)
8.2 Europe Molecular Diagnostics Systems Sales Quantity by Application (2019-2030)
8.3 Europe Molecular Diagnostics Systems Market Size by Country
8.3.1 Europe Molecular Diagnostics Systems Sales Quantity by Country (2019-2030)
8.3.2 Europe Molecular Diagnostics Systems Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Molecular Diagnostics Systems Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Molecular Diagnostics Systems Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Molecular Diagnostics Systems Market Size by Region
9.3.1 Asia-Pacific Molecular Diagnostics Systems Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Molecular Diagnostics Systems Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
10.1 South America Molecular Diagnostics Systems Sales Quantity by Type (2019-2030)
10.2 South America Molecular Diagnostics Systems Sales Quantity by Application (2019-2030)
10.3 South America Molecular Diagnostics Systems Market Size by Country
10.3.1 South America Molecular Diagnostics Systems Sales Quantity by Country (2019-2030)
10.3.2 South America Molecular Diagnostics Systems Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Molecular Diagnostics Systems Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Molecular Diagnostics Systems Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Molecular Diagnostics Systems Market Size by Country
11.3.1 Middle East & Africa Molecular Diagnostics Systems Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Molecular Diagnostics Systems Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
12.1 Molecular Diagnostics Systems Market Drivers
12.2 Molecular Diagnostics Systems Market Restraints
12.3 Molecular Diagnostics Systems Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Molecular Diagnostics Systems and Key Manufacturers
13.2 Manufacturing Costs Percentage of Molecular Diagnostics Systems
13.3 Molecular Diagnostics Systems Production Process
13.4 Molecular Diagnostics Systems Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Molecular Diagnostics Systems Typical Distributors
14.3 Molecular Diagnostics Systems Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Abbott Laboratories
Qiagen N.V.
Roche Diagnostics
Hologic, Inc.
Grifols
Siemens Healthcare
Becton, Dickinson and Company
Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
Biom茅rieux Sa
Cepheid Inc
听
听
*If Applicable.
